Advocate Medical Group - Beverly Center

CLIA Laboratory Citation Details

2
Total Citations
6
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 14D0900618
Address 9831 S Western Avenue, Chicago, IL, 60643
City Chicago
State IL
Zip Code60643
Phone(773) 445-3500

Citation History (2 surveys)

Survey - December 15, 2022

Survey Type: Special

Survey Event ID: XRC811

Deficiency Tags: D2016 D2130 D6000 D6016

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on desk review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 0155D Individual Laboratory Profile and the Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing (PT) records confirmed the laboratory's initial unsuccessful PT performance for the hematology analyte hemoglobin for two of three PT events in 2022 (event 1 and 3 of 2022) and the subsequent unsuccessful PT performance for the hematology analyte hematocrit for three of five PT events from 2021 through 2022 (event 2 of 2021 and event 1 and 3 of 2022). See D2130. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on desk review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 0155D Individual Laboratory Profile and the Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing (PT) records the laboratory failed to achieve satisfactory performance for the hematology analyte hemoglobin for two of three PT events in 2022 (event 1 and 3 of 2022) and hematocrit for three of five PT events from 2021 through 2022 (event 2 of 2021 and event 1 and 3 of 2022). Findings include: 1. Review of the CASPER Report 0155D, generated on 12-01-2022, the laboratory received the following unsatisfactory analyte scores: Hematocrit EVENT 2, 2021 0% Unsatisfactory EVENT 1, 2022 60% Unsatisfactory EVENT 3, 2022 0% Unsatisfactory Hemoglobin EVENT 1, 2022 60% Unsatisfactory EVENT 3, 2022 0% Unsatisfactory 2. Review of WSLH PT records confirmed the laboratory received the following unsatisfactory analyte scores: Hematocrit EVENT 2, 2021 0% Unsatisfactory EVENT 1, 2022 60% Unsatisfactory EVENT 3, 2022 0% Unsatisfactory Hemoglobin EVENT 1, 2022 60% Unsatisfactory EVENT 3, 2022 0% Unsatisfactory D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on desk review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 0155D Individual Laboratory Profile and Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing (PT) records the laboratory director failed to ensure successful participation in an Health and Human Services (HHS) approved PT program for the specialty of hematology (see D6016) resulting in the laboratory's subsequent unsuccessful PT performance for the hematology analyte hematocrit and the initial unsuccessful PT performance for hemoglobin. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(i) Ensure that the proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: -- 2 of 3 -- Based on desk review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 0155D Individual Laboratory Profile and the Wisconsin State Laboratory of Hygiene (WSLH) Proficiency Testing (PT) records the laboratory director failed to ensure successful participation in an Health and Human Services (HHS) approved PT program for the specialty of hematology (see D2130) resulting in the laboratory's subsequent unsuccessful PT performance for the hematology analyte hematocrit and the initial unsuccessful PT performance for hemoglobin. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 2, 2022

Survey Type: Special

Survey Event ID: G7GF11

Deficiency Tags: D2016 D2130

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of the CASPER Report 0155D and interview with a Wisconsin State Laboratory of Hygiene (WSLH) representative the laboratory failed to successfully participate in proficiency testing (PT) for the hematology analyte hematocrit (HCT) during event two of 2021 and event one of 2022. See D2130. D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of the CASPER Report 0155D and interview with a Wisconsin State Laboratory of Hygiene (WSLH) representative the laboratory failed to successfully participate in proficiency testing (PT) for the hematology analyte hematocrit (HCT) during event two of 2021 and event one of 2022. Findings include: 1. Review of the CASPER Report 0155D revealed that the unsuccessful PT performance occurred during WSLH PT event 2 of 2021 and event one of 2022, as listed below. Hematology EVENT -2, 2021 HCT - 0% Unsatisfactory EVENT -1, 2022 HCT - 60% Unsatisfactory 2. A phone interview with the WSLH PT representative on 5-2-22 at 11:29 am confirmed the unsuccessful PT performance for the analyte HCT for event two of 2021 and event one of 2022. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access